Cite
HARVARD Citation
Smith, P. et al. (n.d.). P496 Efficacy and safety of elective switching of inflammatory bowel disease patients from intravenous to subcutaneous infliximab (IFX): a multi-centre cohort study. Journal of Crohn's and colitis. pp. S480-S481. [Online].